Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
Is pulmonary arterial hypertension really a late complication of systemic sclerosis
Chest, 10/12/09
Hachulla E et al. . –In contrast to the expected scenario, early onset PAH occurred in approximately half of SSc patients. Early onset PAH was as frequent among patients with diffuse as limited SSc. Annual screening for PAH should be implemented immediately after SSc diagnosis for all patients.
Methods- Clinical and hemodynamic data at time of diagnosis collected retrospectively
- 78 consecutive patients with SSc associated PAH
- PAH diagnosed within 5 years of SSc considered early onset complication
- PAH diagnosed > 5 years following SSc diagnosis considered a late complication
- PAH occurred 6.3 ± 6.6 years after diagnosis of SSc (median delay 4.0 years)
- Early onset PAH diagnosed in 43 patients (55.1%) and late onset PAH in 35 patients (44.9%)
- Patients with early onset PAH older at SSc diagnosis than patients with late onset (58.0 ± 12.5 vs 46.6 ± 12.9 years)
- No differences in age at time of PAH diagnosis, or SSc subtype (limited vs diffuse; anticentromere vs anti-Scl70 antibodies), observed between onset subgroups
- At diagnosis, early onset PAH more severe than late onset, with lower cardiac index (2.4 ± 0.6 vs 2.8 ± 0.6 L/min/m2) and greater total pulmonary resistance (1,708 ± 777 vs 1,341 ± 530 dyn|b1sec/cm5/m2)
- Mortality at 3 and 5 years comparable between subgroups
Related Articles
Pulmonary hypertension in pregnancy: two cases and review of the literature
Internal Medicine Journal, 11/11/09
Relevance Score: 87%
Bosentan: A Review of its Use in the Management of Mildly Symptomatic Pulmonary Arterial Hypertension
American Journal of Cardiovascular Drugs, 10/08/09
Relevance Score: 85%
Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis
Internal Medicine Journal, 10/21/09
Relevance Score: 84%
Right Ventricular Free Wall Pacing Improves Cardiac Pump Function in Severe Pulmonary Arterial Hypertension: a Computer Simulation Analysis
Heart And Circulatory Physiology, 10/20/09
Relevance Score: 84%
Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)
Journal of Rheumatology, 10/15/09
Relevance Score: 84%
Today in Autoimmune/Heritable...keeping you current
Receive free subspecialty "5-minute updates" via email
Identification of anti-prothrombin antibodies in the anti-phospholipid syndrome that display the prothrombinase activity
Rheumatology, 11/20/09
T Cell Responses to Steroid Cytochrome P450 21-Hydroxylase in Patients with Autoimmune Primary Adrenal Insufficiency
Journal of Clinical Endocrinology and Metabolism, 11/20/09
Raised concentration of soluble form of vascular endothelial cadherin and IL-23 in sera of patients with Behçets disease
Modern Rheumatology, 11/19/09
Today in Connective Tissue Dz...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of Sildenafil on digital ulcers in systemic sclerosis - analysis from a single centre pilot study
Annals of Rheumatic Diseases, 11/22/09
Association of interleukin 23 receptor polymorphisms with anti-topoisomerase-I positivity and pulmonary hypertension in systemic sclerosis
Journal of Rheumatology, 11/20/09
The clinical course of polymyalgia rheumatica in Chinese
Clinical Rheumatology, 11/19/09
Sponsor
Article Search
Sponsor


See Latest Articles


